Novel Hep B Drug Delivers Functional Cures in Late-Stage Trials

(MedPage Today) -- Treatment with the investigational antisense oligonucleotide bepirovirsen led to functional cure in one in five patients with chronic hepatitis B virus (HBV) infection, the phase III B-Well 1 and B-Well 2 trials showed. Among...
Source
MedPage Today
Opens original article in a new tab



